China Fibrin Sealant (Human) Market to 2022: Number of Surgical Operations will Continue to Rise, Which will Help Expand the Market
DUBLIN, Jan. 8, 2019 /PRNewswire/ --
The "Investigation Report on China's Fibrin Sealant (Human) Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering.
Fibrin sealant, also known as fibrin glue, is a biological product commonly used in surgery. Fibrin Sealant (Human) is a blood product that can help treat burn wounds, abdominal incisions in general surgery, incisions in liver surgery, and incisions in vascular surgery by stopping bleeding and covering and sealing wounds.
In China, the accidental deaths and burns rank only second to traffic injuries. And the traffic injuries also include many burns. The annual incidence of burns in China is about 1.5% to 2%, which means that about 20 million people suffer burns every year. And about 5% of the burn victims need hospitalization. From Jan. to Sept. 2018, the number of people discharged from China's medical and health institutions reached 185,577,000, increasing by 6.4% YOY, and a large proportion of the inpatients had surgery.
The sales value of Fibrin Sealant (Human) has been rising since the drug was launched in China, reaching about CNY 144 million in 2017. According to this market research, China's Fibrin Sealant (Human) market is dominated by Shanghai RAAS Blood Products Co., Ltd. and Hualan Biological Engineering Inc., and the former has a market share of more than 90% by sales value.
It is expected that in the next few years, with the lifestyle changes brought about by economic development and the rising incidences of various diseases caused by population aging, the number of surgical operations in China will continue to rise, which will help expand the market size of Fibrin Sealant (Human).
Key Topics Covered:
1 Relevant Concepts of Fibrin Sealant (Human)
1.1 Indications for Fibrin Sealant (Human)
1.2 Development of Fibrin Sealant (Human) in China
1.3 Governmental Approval of Fibrin Sealant (Human) in China
2 Sales of Fibrin Sealant (Human) in China, 2013-2017
2.1 Sales Value of Fibrin Sealant (Human)
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Fibrin Sealant (Human)
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Fibrin Sealant (Human) by Dosage Form in China, 2013-2017
2.3.1 Sales of Lyophilized Fibrin Sealant (Human)
2.3.2 Sales of Solutions for Fibrin Sealant (Human)
3 Analysis of Major Manufacturers of Fibrin Sealant (Human) in China, 2013-2017
3.1 Analysis on Market Share of Major Manufacturers of Fibrin Sealant (Human)
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Shanghai RAAS Blood Products Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Shanghai RAAS Blood Products Co., Ltd.'s Fibrin Sealant (Human) in China
3.3 Hualan Biological Engineering Inc.
3.3.1 Enterprise Profile
3.3.2 Sales of Hualan Biological Engineering Inc.'s Fibrin Sealant (Human) in China
4 Prices of Fibrin Sealant (Human) in China, 2017-2018
4.1 Shanghai RAAS Blood Products Co., Ltd. (FIBINGLUEAAS)
4.2 Hualan Biological Engineering Inc. (KangPuXin)
5 Prospect of China's Fibrin Sealant (Human) Market, 2018-2022
5.1 Major Factors Influencing Development of China's Fibrin Sealant (Human) Market.
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
For more information about this report visit https://www.researchandmarkets.com/research/ftmgzx/china_fibrin?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article